Ever Source Wealth Advisors, LLC Lyell Immunopharma, Inc. Transaction History
Ever Source Wealth Advisors, LLC
- $1.66 Billion
- Q1 2025
A detailed history of Ever Source Wealth Advisors, LLC transactions in Lyell Immunopharma, Inc. stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 106 shares of LYEL stock, worth $46. This represents 0.0% of its overall portfolio holdings.
Number of Shares
106Holding current value
$46% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding LYEL
# of Institutions
117Shares Held
175MCall Options Held
2.9KPut Options Held
6K-
Mwg Management Ltd. Washington, DC20.2MShares$8.87 Million18.54% of portfolio
-
Foresite Capital Management Iv, LLC Larkspur, CA16MShares$7.04 Million9.84% of portfolio
-
Orland Properties LTD Washington, DC15.1MShares$6.64 Million9.84% of portfolio
-
Apoletto LTD Washington, DC15.1MShares$6.64 Million42.56% of portfolio
-
Black Rock Inc. New York, NY13.5MShares$5.94 Million0.0% of portfolio
About Lyell Immunopharma, Inc.
- Ticker LYEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 247,824,992
- Market Cap $109M
- Description
- Lyell Immunopharma, Inc., a T cell reprogramming company, engages in developing T cell therapies for patients with solid tumors. The company develops therapies using technology platforms, such as Gen-R, an ex vivo genetic reprogramming technology to overcome T cell exhaustion; and Epi-R, an ex vivo epigenetic reprogramming technology to generate...